Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, Ireland
SEC filing record 1 source field available
Fiscal year end
31 December
Nabriva Therapeutics plc has filed 695 SEC EDGAR filings since 14 May 2015

SEC filing history

Showing 426-450 of 695 matching filings.

Per page
25
Current page
18
SC 13G/A File 005-89113

SCHEDULE 13G/A

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

SC 13G/A

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

VENBIO GLOBAL STRATEGIC FUND II, L.P. / NABRIVA THERAPEUTICS AG - SCHEDULE 13G/A

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

SEC SCHEDULE 13G

Filing date
11 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

SEC SCHEDULE 13G

Filing date
08 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Feb 2019
Reporting date
31 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

SC 13G/A

Filing date
01 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
14 Jan 2019
Reporting date
14 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
04 Jan 2019
Reporting date
04 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Dec 2018
Reporting date
24 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
21 Dec 2018
Reporting date
20 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37558

CT ORDER filing

Filing date
29 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
06 Nov 2018
Reporting date
06 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-228094

S-8

Filing date
31 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37558

8-K

Filing date
31 Oct 2018
Reporting date
31 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37558

DEF 14A

Filing date
01 Oct 2018
Reporting date
31 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37558

PRE 14A

Filing date
10 Sep 2018
Reporting date
10 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-37558

8-K/A

Filing date
10 Sep 2018
Reporting date
23 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

SEC SCHEDULE 13G

Filing date
10 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .